These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29120405)

  • 1. Site-Specific Antibody Conjugation for ADC and Beyond.
    Zhou Q
    Biomedicines; 2017 Nov; 5(4):. PubMed ID: 29120405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
    Zhou Q; Kim J
    Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current methods for the synthesis of homogeneous antibody-drug conjugates.
    Sochaj AM; Świderska KW; Otlewski J
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
    Yamada K; Ito Y
    Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.
    Zimmerman ES; Heibeck TH; Gill A; Li X; Murray CJ; Madlansacay MR; Tran C; Uter NT; Yin G; Rivers PJ; Yam AY; Wang WD; Steiner AR; Bajad SU; Penta K; Yang W; Hallam TJ; Thanos CD; Sato AK
    Bioconjug Chem; 2014 Feb; 25(2):351-61. PubMed ID: 24437342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins.
    Zhou Q
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of site-specific methods for achieving antibody drug conjugates with homogenous drug to antibody ratio.
    Hingorani DV
    Expert Opin Biol Ther; 2024; 24(1-2):31-36. PubMed ID: 38247196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Feb; 18(1):1-17. PubMed ID: 26754790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation.
    Yoder NC; Bai C; Tavares D; Widdison WC; Whiteman KR; Wilhelm A; Wilhelm SD; McShea MA; Maloney EK; Ab O; Wang L; Jin S; Erickson HK; Keating TA; Lambert JM
    Mol Pharm; 2019 Sep; 16(9):3926-3937. PubMed ID: 31287952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody conjugates with unnatural amino acids.
    Hallam TJ; Wold E; Wahl A; Smider VV
    Mol Pharm; 2015 Jun; 12(6):1848-62. PubMed ID: 25898256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status: Site-Specific Antibody Drug Conjugates.
    Schumacher D; Hackenberger CP; Leonhardt H; Helma J
    J Clin Immunol; 2016 May; 36 Suppl 1():100-7. PubMed ID: 27003914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates.
    Puthenveetil S; Musto S; Loganzo F; Tumey LN; O'Donnell CJ; Graziani E
    Bioconjug Chem; 2016 Apr; 27(4):1030-9. PubMed ID: 26942771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation.
    Matsuda Y; Malinao MC; Robles V; Song J; Yamada K; Mendelsohn BA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121981. PubMed ID: 32036254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody drug conjugates.
    Bakhtiar R
    Biotechnol Lett; 2016 Oct; 38(10):1655-64. PubMed ID: 27334710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].
    Tsuchikama K
    Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unnatural amino acids in novel antibody conjugates.
    Hallam TJ; Smider VV
    Future Med Chem; 2014 Jul; 6(11):1309-24. PubMed ID: 25163001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase.
    El Alaoui M; Sivado E; Jallas AC; Mebarki L; Dyson MR; Perrez F; Valsesia-Wittmann S; El Alaoui S
    Cell Death Discov; 2024 Feb; 10(1):79. PubMed ID: 38360912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.